Sex Differences in the Treatment of HIV
- 11 June 2020
- journal article
- research article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 17 (4) , 373-384
Abstract
Purpose of Review Biological and societal influences are different for men and women leading to different HIV outcomes and related infectious and non-infectious complications. This review evaluates sex differences in the epidemiology and immunological response to HIV and looks at major complications and coinfections, as well as care delivery systems focusing on low- and middle-income countries (LMICs) where most people with HIV live. Recent Findings More women than men access testing and treatment services in LMIC; women are more likely to be virologically suppressed in that environment. There is a growing recognition that the enhanced immunological response to several pathogens including HIV may result in improved outcomes for infectious comorbidities but may result in a greater burden of non-communicable diseases. Summary Men and women have different requirements for HIV care. Attention to these differences may improve outcomes for all.Keywords
This publication has 125 references indexed in Scilit:
- The Role of Host Gender in the Pathogenesis of Cryptococcus neoformans InfectionsPLOS ONE, 2013
- Outcomes of Antiretroviral Treatment Programs in Rural Southern AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Sex Differences in Lopinavir and Ritonavir Pharmacokinetics Among HIV-Infected Women and MenThe Journal of Clinical Pharmacology, 2011
- Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohortEuropean Heart Journal, 2011
- Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated With Noncalcified Coronary Plaque in HIV-Infected PatientsThe Journal of Infectious Diseases, 2011
- Poorer ART Outcomes with Increasing Age at a Large Public Sector HIV Clinic in Johannesburg, South AfricaJournal of the International Association of Physicians in AIDS Care, 2011
- Plasma sCD14 Is a Biomarker Associated With Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV InfectionThe Journal of Infectious Diseases, 2011
- Sex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 InfectionThe Journal of Infectious Diseases, 2011
- Trends in the incidence of primary liver cancer in Central Uganda, 1960–1980 and 1991–2005British Journal of Cancer, 2009